New combo therapy aims to tame Tough-to-Treat head & neck cancer recurrence
Disease control
Recruiting now
This study is testing a two-part treatment for recurrent nasopharyngeal cancer (a type of head and neck cancer) in patients who are not candidates for surgery. First, patients receive a short course of targeted radiation combined with an immunotherapy drug. After a break, they re…
Phase: PHASE2 • Sponsor: Jiangxi Provincial Cancer Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC